DrugInfoSys

Docetaxel

Drug #893

Docetaxel is antineoplastic agent, also known as anticancerous drug, is an alkaloid ester derived from the wastern yew and european yew. It has been approved recently for clinical use. Docetaxel is effective in the treatment of different cancers (e.g., ovarian and breast cancer) to slow or stop the growth of cancerous or abnormal cells. Docetaxel is used in combination with different anticancerous drugs to obtain best therapeutic results and reduce toxicity or side effects.

Primary Characteristics

It is of Semi Synthetic origin and belongs to Taxol Trihydrate.

It is classified in Antineoplastic Agent, Antimicrotubular pharmacological group.

Molecular Weight: 861.94 · Solubility in Water: insoluble · Solubility in Alcohol: null · Non-proprietary name: Docetaxel.

Molecular structure of Docetaxel

Pharmacokinetics

Distribution: Docetaxel has a volume of distribution is 67.3 l/m2. plasma protein binding is > 95%.

Elimination: it is metabolised via extensive by liver, plasma half-life is 11-18 hr (terminal), renal excretion is < 10%.

Advertisement

Indications

Contraindications

Docetaxel is contraindicated in conditions like Neutropenia, Severe liver impairment.

Dosage

Docetaxel's dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
80 mg/ sq.meter80 mg/ sq.meterIV InfOver 1 hour, repeated every 3 weeks
Paediatric Dosage (20kg)
0 – 0Not recommended in this age group
Neonatal Dosage (3kg)
0 – 0Not recommended in this age group

Drug Interactions

Unknown4 interactions
3 interactions

Always consult your physician for the change of dose regimen or an alternative drug of choice that may strictly be required.

Side Effects

Docetaxel in overdosage may give rise to further complications which include Sensory neuropathy, Neurotoxicity , Hypersensitivity reactions .

Docetaxel produces potentially life-threatening effects which include Neutropenia , Fluid retention syndrome. Careful monitoring is needed with proper medical management.

The signs and symptoms that are produced after acute overdosage of Docetaxel are Mild paresthesia, Cutaneous reactions, Neutropenia , Asthenia.

Docetaxel is known to cause more or less tolerable side effects which are usually transient. These include Alopecia, Arthralgia, Cutaneous reaction, Diarrhea, Elevation of liver enzymes, Eruptions, Erythematous rash, Fatigue, Fever, Flushing, Malaise, Mucositis, Nail discoloration, Nausea, Neutropenia, Onycholysis, Pruritus , Reaction at injection site, StomatitisX, Thrombocytopenia, Urticaria, Vomiting , Weight gain.

Warnings / Precautions

Docetaxel should be used cautiously in patients with pre-existing edema, ascites, or effusions, in hepatic disease because the drug is hepatically metabolized. It should not be given to patients with bilirubin levels greater than the upper limit of normal (ULN) or to patients with SGOT and/or SGPT greater than 1.5 times the ULN concomitant with alkaline phosphatase > 2.5 times the ULN. Bilirubin, SGOPT or SGPT and alkaline phosphatase values should be obtained before each cycle of docetaxel. It should be used with caution in patients with a baseline neutrophil count of less than 1500 cells/cubic mm, with any pre-existing heart disease, bone marrow disorders, or a history of allergic reactions. It is classified as pregnancy category D. It is not recommended during pregnancy or lactation.

Interference in Pathology

Docetaxel may interfere in the diagnosis of Liver Function Test (LFT) , Complete blood cell count.

Available Brands

Click on a strength to view available brands.

Storage Conditions

Docetaxel should be stored Inj.

Drug Classification

  1. 1.8.2Cytotoxic (anti-neoplastic) drugs

Manufacturers